Immunogenicity of Biologic Treatments for Psoriasis: Therapeutic Consequences and the Potential Value of Concomitant Methotrexate
Crossref DOI link: https://doi.org/10.1007/s40257-015-0131-y
Published Online: 2015-05-12
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Farhangian, Michael E.
Feldman, Steven R.
Text and Data Mining valid from 2015-05-12